MAPK8 and Alzheimer disease: Our study explores the Mnat9-JNK interaction in AD, which presents an interesting opportunity of targeting AD progression by evaluating inhibitors of cell death signals (like JNK) downstream of amyloid plaques/ neurofibrillary tangles.